Regulatory
Icarus files late 2024 financials, has CTO revoked

ICRS · Price
Executive Summary
- The British Columbia Securities Commission has revoked the cease trade order (CTO) previously issued against Icarus Capital Corp.
- The CTO was originally issued due to delays in filing annual audited financial statements, MD&A, and certifications for the year ended December 31, 2024, following the death of the former CFO.
- The company has now completed its audit, filed all required documents, paid outstanding fees, and secured working capital through a private placement.
- Trading on the TSX Venture Exchange remains suspended pending a review of the company's listing status, though active discussions with the exchange are ongoing.
Key Details
- CTO Revocation: The BC Securities Commission revoked the cease trade order that had been in effect since May 6, 2025.
- Reason for Original CTO: The order was issued due to the issuer's delay in filing:
- Annual audited financial statements
- Management’s Discussion and Analysis (MD&A)
- Certifications for the year ended December 31, 2024
- Cause of Delay: The delay was attributed to the unexpected passing of the issuer's former chief financial officer in March.
- Resolution Actions:
- Completed the audit.
- Filed first quarter interim financial statements.
- Paid all outstanding fees.
- Private Placement Financing:
- Structure: Private placement of units.
- Quantity: 2.01 million units.
- Price: 10 cents per unit.
- Gross Proceeds: $201,000.
- Use of Proceeds: Completed the audit, filed financial statements, and provided working capital.
- Trading Status:
- Shares remain suspended on the TSX Venture Exchange.
- Suspension is pending the exchange's review of Icarus's listing status.
- The company is in active discussions with the TSX Venture Exchange.
- A market update will be provided once reinstatement to trading is confirmed.
Notable Quotes
- No direct quotes from management were included in the provided text.
More from Icarus Capital Corp
Jun 15, 2026 · 15:55